Reply to the letter regarding ‘Prognostic value of left atrial reverse remodelling in patients hospitalized with ADHF’

IF 3.7 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS ESC Heart Failure Pub Date : 2024-10-23 DOI:10.1002/ehf2.15142
Sakura Nagumo, Mio Ebato, Takuya Mizukami, Yoshitaka Iso, Hiroshi Suzuki
{"title":"Reply to the letter regarding ‘Prognostic value of left atrial reverse remodelling in patients hospitalized with ADHF’","authors":"Sakura Nagumo,&nbsp;Mio Ebato,&nbsp;Takuya Mizukami,&nbsp;Yoshitaka Iso,&nbsp;Hiroshi Suzuki","doi":"10.1002/ehf2.15142","DOIUrl":null,"url":null,"abstract":"<p>We thank Hao Zhang et al. for their interest in our work and would like to respond to their comments regarding our study.<span><sup>1</sup></span></p><p>In our study, because we defined the primary endpoint as a composite of heart failure (HF) rehospitalization or cardiovascular death, a Cox regression analysis was conducted. We acknowledge that using a Cox regression model can lead to an overestimation of the cumulative event incidence in the presence of competing events. Therefore, additional analyses using Fine–Gray competing risks models were conducted. Fine–Gray competing risks models also demonstrated that patients with left atrial reverse remodelling (LARR) had significantly better prognoses for cardiovascular death (<i>P</i> = 0.026) and HF rehospitalization (<i>P</i> = 0.0007). Among the 117 individuals who reached the primary endpoint, 109 experienced rehospitalization for HF, and 8 died due to cardiovascular events (5 related to HF and 3 due to non-HF causes). This finding indicated that the majority of events were related to HF and that the incidence of competing events (i.e., cardiovascular death without HF worsening) was quite low. Therefore, we believe that the implication of using a competing risk model in this context is limited.</p><p>We agree that cardiogenic shock (CS) is associated with poor outcomes; however, other factors such as age and chronic kidney disease also affect long-term prognosis.<span><sup>2, 3</sup></span> To investigate the relationship between CS and long-term outcomes, it is crucial to consider the presence of CS during the current hospitalization and also any previous CS history. However, collecting this historical information poses challenges. In this present study, patients with in-hospital death were excluded, and selected patients who underwent two-point echocardiography with adequate quality for calculating LARR were included. Thus, the number of patients with CS was low, leading us to conclude that CS was not an appropriate factor for multivariate analysis in this study.</p><p>Frailty is another important factor for patients with HF. Recent reports indicate that physical frailty, cognitive dysfunction and social isolation are associated with poor outcomes in patients with HF.<span><sup>4, 5</sup></span> In this study, because of the lack of data on cognitive dysfunction and social environment, we focused our additional analysis solely on physical frailty. Similar to previous reports,<span><sup>6, 7</sup></span> physical frailty emerged as a significant prognostic factor (<i>P</i> = 0.031). However, in the multivariate analysis, the significance of frailty was attenuated, suggesting that factors such as male sex, anaemia, no beta-blocker use, non-LARR and history of prior HF hospitalization had more substantial effects on adverse events.</p><p>Although diabetes itself may worsen HF, it is also associated with other risk factors such as ischaemic heart disease and renal dysfunction. In the Seattle Heart Failure Model, a well-established risk score for mortality in patients with HF, diabetes is not included in the calculation.<span><sup>8</sup></span> In our study, because diabetes did not show a significant difference in the univariate analysis (<i>P</i> = 0.358), we did not include it in the multivariate analysis. Hao Zhang et al. proposed a subgroup analysis of diabetes; however, since only 40% of the participants had diabetes, the power was insufficient for a meaningful subgroup analysis. Furthermore, the age at diabetes onset was not recorded in our study, making it difficult to incorporate this variable into additional analyses. We believe that further investigation is warranted in the future.</p>","PeriodicalId":11864,"journal":{"name":"ESC Heart Failure","volume":"12 1","pages":"706-707"},"PeriodicalIF":3.7000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11769623/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESC Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ehf2.15142","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

We thank Hao Zhang et al. for their interest in our work and would like to respond to their comments regarding our study.1

In our study, because we defined the primary endpoint as a composite of heart failure (HF) rehospitalization or cardiovascular death, a Cox regression analysis was conducted. We acknowledge that using a Cox regression model can lead to an overestimation of the cumulative event incidence in the presence of competing events. Therefore, additional analyses using Fine–Gray competing risks models were conducted. Fine–Gray competing risks models also demonstrated that patients with left atrial reverse remodelling (LARR) had significantly better prognoses for cardiovascular death (P = 0.026) and HF rehospitalization (P = 0.0007). Among the 117 individuals who reached the primary endpoint, 109 experienced rehospitalization for HF, and 8 died due to cardiovascular events (5 related to HF and 3 due to non-HF causes). This finding indicated that the majority of events were related to HF and that the incidence of competing events (i.e., cardiovascular death without HF worsening) was quite low. Therefore, we believe that the implication of using a competing risk model in this context is limited.

We agree that cardiogenic shock (CS) is associated with poor outcomes; however, other factors such as age and chronic kidney disease also affect long-term prognosis.2, 3 To investigate the relationship between CS and long-term outcomes, it is crucial to consider the presence of CS during the current hospitalization and also any previous CS history. However, collecting this historical information poses challenges. In this present study, patients with in-hospital death were excluded, and selected patients who underwent two-point echocardiography with adequate quality for calculating LARR were included. Thus, the number of patients with CS was low, leading us to conclude that CS was not an appropriate factor for multivariate analysis in this study.

Frailty is another important factor for patients with HF. Recent reports indicate that physical frailty, cognitive dysfunction and social isolation are associated with poor outcomes in patients with HF.4, 5 In this study, because of the lack of data on cognitive dysfunction and social environment, we focused our additional analysis solely on physical frailty. Similar to previous reports,6, 7 physical frailty emerged as a significant prognostic factor (P = 0.031). However, in the multivariate analysis, the significance of frailty was attenuated, suggesting that factors such as male sex, anaemia, no beta-blocker use, non-LARR and history of prior HF hospitalization had more substantial effects on adverse events.

Although diabetes itself may worsen HF, it is also associated with other risk factors such as ischaemic heart disease and renal dysfunction. In the Seattle Heart Failure Model, a well-established risk score for mortality in patients with HF, diabetes is not included in the calculation.8 In our study, because diabetes did not show a significant difference in the univariate analysis (P = 0.358), we did not include it in the multivariate analysis. Hao Zhang et al. proposed a subgroup analysis of diabetes; however, since only 40% of the participants had diabetes, the power was insufficient for a meaningful subgroup analysis. Furthermore, the age at diabetes onset was not recorded in our study, making it difficult to incorporate this variable into additional analyses. We believe that further investigation is warranted in the future.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
回复关于 "左心房逆向重塑对 ADHF 住院患者的预后价值 "的信件。
我们感谢张浩等人对我们的工作感兴趣,并希望回复他们对我们研究的评论。在我们的研究中,由于我们将主要终点定义为心力衰竭(HF)再住院或心血管死亡的复合终点,因此进行了Cox回归分析。我们承认,在存在竞争事件的情况下,使用Cox回归模型可能导致对累积事件发生率的高估。因此,使用Fine-Gray竞争风险模型进行了额外的分析。细灰色竞争风险模型还显示,左心房反向重构(LARR)患者心血管死亡(P = 0.026)和心衰再住院(P = 0.0007)的预后明显更好。在达到主要终点的117名患者中,109人因HF再次住院,8人死于心血管事件(5人与HF有关,3人死于非HF原因)。这一发现表明,大多数事件与心衰有关,而竞争事件(即无心衰恶化的心血管死亡)的发生率相当低。因此,我们认为在这种情况下使用竞争风险模型的含义是有限的。我们同意心源性休克(CS)与不良预后相关;然而,年龄和慢性肾脏疾病等其他因素也会影响长期预后。2,3为了研究CS与长期预后之间的关系,考虑当前住院期间CS的存在以及任何既往CS史是至关重要的。然而,收集这些历史信息带来了挑战。在本研究中,排除了院内死亡的患者,并选择了接受两点超声心动图检查且质量足以计算LARR的患者。因此,CS患者数量较少,因此我们认为CS不是本研究中适合进行多变量分析的因素。虚弱是心衰患者的另一个重要因素。最近的报道表明,身体虚弱、认知功能障碍和社会隔离与hf患者的不良预后相关。在本研究中,由于缺乏认知功能障碍和社会环境的数据,我们只关注身体虚弱的附加分析。与之前的报道相似,6,7身体虚弱是一个重要的预后因素(P = 0.031)。然而,在多变量分析中,虚弱的重要性被减弱,这表明男性、贫血、未使用β受体阻滞剂、非larr和既往HF住院史等因素对不良事件的影响更为显著。虽然糖尿病本身可能加重心衰,但它也与其他危险因素有关,如缺血性心脏病和肾功能不全。在西雅图心力衰竭模型中,心衰患者死亡率的一个成熟的风险评分,糖尿病不包括在计算中在我们的研究中,由于糖尿病在单因素分析中没有显示出显著差异(P = 0.358),所以我们没有将其纳入多因素分析。Hao Zhang等人提出了糖尿病的亚组分析;然而,由于只有40%的参与者患有糖尿病,这种力量不足以进行有意义的亚组分析。此外,我们的研究中没有记录糖尿病发病年龄,因此很难将这一变量纳入其他分析中。我们认为未来有必要进行进一步调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ESC Heart Failure
ESC Heart Failure Medicine-Cardiology and Cardiovascular Medicine
CiteScore
7.00
自引率
7.90%
发文量
461
审稿时长
12 weeks
期刊介绍: ESC Heart Failure is the open access journal of the Heart Failure Association of the European Society of Cardiology dedicated to the advancement of knowledge in the field of heart failure. The journal aims to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is heart failure. Accordingly, submission of manuscripts on basic, translational, clinical and population sciences is invited. Original contributions on nursing, care of the elderly, primary care, health economics and other specialist fields related to heart failure are also welcome, as are case reports that highlight interesting aspects of heart failure care and treatment.
期刊最新文献
Endothelial and inflammatory responses during ex vivo normothermic perfusion of human cardiac grafts. Worsening Heart Failure-Based Hierarchical Endpoints Beyond HF Hospitalization. Expert opinion paper. Glucagon-Like Peptide-1 Receptor Agonists in Patients with Heart Failure with Reduced Ejection Fraction. Metrics of Left Ventricular Active Relaxation Reflect Proteomic Myocardial Remodelling and Reverse Remodelling. Prognosis of Tricuspid Regurgitation after Mitral Transcatheter Edge-to-Edge Repair: The EXPANDed Studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1